Medline Inc.
MDLN
$34.05
-$0.64-1.85%
NASDAQ
| 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 29.94B | 29.14B | 28.43B | 27.43B | 26.70B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.94B | 29.14B | 28.43B | 27.43B | 26.70B |
| Cost of Revenue | 22.09B | 21.61B | 20.91B | 19.97B | 19.37B |
| Gross Profit | 7.85B | 7.54B | 7.52B | 7.46B | 7.34B |
| SG&A Expenses | 4.90B | 4.70B | 4.56B | 4.46B | 4.33B |
| Depreciation & Amortization | 706.00M | 705.00M | 704.00M | 705.00M | 701.00M |
| Other Operating Expenses | 401.00M | 67.00M | 60.00M | 46.00M | 60.00M |
| Total Operating Expenses | 28.11B | 27.07B | 26.23B | 25.18B | 24.45B |
| Operating Income | 1.83B | 2.07B | 2.20B | 2.25B | 2.25B |
| Income Before Tax | 1.08B | 1.20B | 1.25B | 1.35B | 1.34B |
| Income Tax Expenses | 197.00M | 127.00M | 91.00M | 81.00M | 72.00M |
| Earnings from Continuing Operations | 880.00 | 1.07K | 1.16K | 1.27K | 1.27K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -187.00M | -108.00M | 2.00M | -- | -- |
| Net Income | 693.00M | 966.00M | 1.16B | 1.27B | 1.27B |
| EBIT | 1.83B | 2.07B | 2.20B | 2.25B | 2.25B |
| EBITDA | 2.86B | 3.09B | 3.21B | 3.25B | 3.25B |
| EPS Basic | 0.48 | 0.43 | 0.28 | 0.07 | 0.05 |
| Normalized Basic EPS | 0.39 | 0.33 | 0.24 | 0.04 | 0.02 |
| EPS Diluted | 0.47 | 0.42 | 0.28 | 0.07 | 0.05 |
| Normalized Diluted EPS | 0.39 | 0.33 | 0.24 | 0.04 | 0.02 |
| Average Basic Shares Outstanding | 19.97B | 36.61B | 35.79B | 52.45B | 34.97B |
| Average Diluted Shares Outstanding | 19.98B | 36.62B | 53.26B | 69.92B | 52.44B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 31.02% | 53.62% | 44.69% | 140.68% | 134.38% |